-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $350

Benzinga·07/31/2026 18:36:22
語音播報
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $400 to $350.